Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Mol Genet Genomic Med ; 9(4): e1640, 2021 04.
Artículo en Inglés | MEDLINE | ID: mdl-33656256

RESUMEN

BACKGROUND: Creatine transporter deficiency is an inborn error of metabolism caused by a deficiency in the creatine transporter protein encoded by the SLC6A8 gene. Previous treatment with creatine supplementation, either alone or in combination with creatine precursors (arginine or glycine), has been attempted; the efficacy of therapy, however, remains controversial. METHODS AND RESULTS: To analyze the treatment efficacy of high-dose creatine supplementation on creatine transporter deficiency, we reported a child diagnosed with creatine transporter deficiency, who was treated with a conventional dose of creatine (400 mg/kg/d) for 1 month, then twice the dose (800 mg/kg/d) for 2 months, and finally 3 times the dose (1200 mg/kg/d) for 3 months. The patient tolerated the treatment well and showed improvements in muscle mass and strength when the creatine dose was gradually increased to 1200 mg/kg/d. However, when assessed by proton magnetic resonance spectroscopy (H-MRS), the brain creatine concentration did not increase, and there was no improvement in speech and neurodevelopmental symptoms. CONCLUSION: We conclude that high-dose creatine supplementation (1200 mg/kg/d) alone improved muscular symptoms, but did not improve cognitive symptoms and brain creatine concentration assessed using H-MRS. Therefore, new treatment strategies are required for the management of creatine transporter deficiency.


Asunto(s)
Creatina/uso terapéutico , Discapacidades del Desarrollo/tratamiento farmacológico , Errores Innatos del Metabolismo/tratamiento farmacológico , Proteínas del Tejido Nervioso/genética , Proteínas de Transporte de Neurotransmisores en la Membrana Plasmática/genética , Niño , Cognición , Creatina/administración & dosificación , Creatina/efectos adversos , Discapacidades del Desarrollo/genética , Discapacidades del Desarrollo/patología , Suplementos Dietéticos , Tolerancia a Medicamentos , Humanos , Desarrollo del Lenguaje , Masculino , Errores Innatos del Metabolismo/genética , Errores Innatos del Metabolismo/patología , Fuerza Muscular , Proteínas del Tejido Nervioso/deficiencia , Proteínas de Transporte de Neurotransmisores en la Membrana Plasmática/deficiencia
2.
Nat Commun ; 12(1): 833, 2021 02 05.
Artículo en Inglés | MEDLINE | ID: mdl-33547280

RESUMEN

The structure of proline prevents it from adopting an optimal position for rapid protein synthesis. Poly-proline-tract (PPT) associated ribosomal stalling is resolved by highly conserved eIF5A, the only protein to contain the amino acid hypusine. We show that de novo heterozygous EIF5A variants cause a disorder characterized by variable combinations of developmental delay, microcephaly, micrognathia and dysmorphism. Yeast growth assays, polysome profiling, total/hypusinated eIF5A levels and PPT-reporters studies reveal that the variants impair eIF5A function, reduce eIF5A-ribosome interactions and impair the synthesis of PPT-containing proteins. Supplementation with 1 mM spermidine partially corrects the yeast growth defects, improves the polysome profiles and restores expression of PPT reporters. In zebrafish, knockdown eif5a partly recapitulates the human phenotype that can be rescued with 1 µM spermidine supplementation. In summary, we uncover the role of eIF5A in human development and disease, demonstrate the mechanistic complexity of EIF5A-related disorder and raise possibilities for its treatment.


Asunto(s)
Discapacidades del Desarrollo/genética , Regulación del Desarrollo de la Expresión Génica , Microcefalia/genética , Micrognatismo/genética , Factores de Iniciación de Péptidos/genética , Proteínas de Unión al ARN/genética , Adolescente , Secuencia de Aminoácidos , Animales , Niño , Discapacidades del Desarrollo/metabolismo , Discapacidades del Desarrollo/patología , Embrión no Mamífero , Femenino , Humanos , Lisina/análogos & derivados , Lisina/genética , Lisina/metabolismo , Masculino , Microcefalia/metabolismo , Microcefalia/patología , Micrognatismo/metabolismo , Micrognatismo/patología , Factores de Iniciación de Péptidos/deficiencia , Péptidos/genética , Péptidos/metabolismo , Biosíntesis de Proteínas , Conformación Proteica , Isoformas de Proteínas/deficiencia , Isoformas de Proteínas/genética , Ribosomas/genética , Ribosomas/metabolismo , Saccharomyces cerevisiae/efectos de los fármacos , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/crecimiento & desarrollo , Saccharomyces cerevisiae/metabolismo , Proteínas de Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/metabolismo , Alineación de Secuencia , Homología de Secuencia de Aminoácido , Espermidina/farmacología , Pez Cebra , Proteínas de Pez Cebra/genética , Proteínas de Pez Cebra/metabolismo , Factor 5A Eucariótico de Iniciación de Traducción
3.
Regul Toxicol Pharmacol ; 120: 104840, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-33321148

RESUMEN

In 2017, JECFA requested reproductive and developmental toxicity studies to finalize an acceptable daily intake for solvent rosemary extracts. Thus, an OECD 421 reproductive/developmental toxicity study was conducted using an acetone rosemary extract that complied with JECFA and EFSA food additive specifications. Rosemary extract was provided to rats at dietary concentrations of 0 (control), 2100, 3600, or 5000 mg/kg, for 14 days before mating, during mating, and thereafter (throughout gestation and up to Lactation Day 13 for females) until necropsy. General toxicity (clinical signs, body weight, food consumption) and reproductive/developmental outcomes (fertility and mating performance, estrous cycles, anogenital distance, thyroid hormones, reproductive organ weights, thyroid histopathology) were assessed. There were no signs of general toxicity and no effects on reproduction; thus, the highest concentration tested (equivalent to mean daily intakes of 316 or 401 mg/kg bw/day [149 or 189 mg/kg bw/day carnosol and carnosic acid] for males and females, respectively) was established as the no-observed-adverse-effect level for general and reproductive toxicity. Dose-related reductions in T4 were observed for Day 13 pups (not seen on Day 4) but were not accompanied by thyroid weight changes or histopathological findings; further investigations are required to determine the biological relevance of these T4 reductions.


Asunto(s)
Acetona/toxicidad , Genitales/efectos de los fármacos , Extractos Vegetales/toxicidad , Reproducción/efectos de los fármacos , Rosmarinus , Animales , Animales Recién Nacidos , Discapacidades del Desarrollo/inducido químicamente , Discapacidades del Desarrollo/patología , Evaluación Preclínica de Medicamentos/métodos , Femenino , Genitales/fisiología , Masculino , Nivel sin Efectos Adversos Observados , Tamaño de los Órganos , Extractos Vegetales/aislamiento & purificación , Embarazo , Ratas , Reproducción/fisiología
4.
Mol Genet Genomic Med ; 9(2): e1582, 2021 02.
Artículo en Inglés | MEDLINE | ID: mdl-33369188

RESUMEN

BACKGROUND: Gabriele-de Vries syndrome (GADEVS), also known as YY1 haploinsufficiency syndrome, is a very rare autosomal dominant neurodevelopmental disorder (NDD) due to YY1 mutation characterized by mild-to-profound developmental delay (DD)/intellectual disability (ID), a wide spectrum of functional and morphologic abnormalities, and intrauterine growth restriction or low birth weight and feeding difficulties are common in the patients. However, NDDs, such as language development disorder and ID, could hardly be assessed in patients younger than 2 years old. METHODS: We describe a 9-month-old female with DD, failure to thrive, and facial dysmorphism. Genetic analysis was conducted by whole exome sequencing (WES) and confirmed by Sanger sequencing. RESULTS: In addition to DD and dysmorphic facial features, this patient had urinary tract infection, acute pyelonephritis, bilateral vesicoureteral reflux (grade III), gastroesophageal reflux, and malnutrition. She was found to have foramen ovale or atrial septal defect, and enlarged left lateral ventricle in the brain. After performing WES, a novel heterozygous mutation NM_003403.5:c.1124G>A, p.Arg375Gln in the YY1 gene was identified. CONCLUSION: Our findings suggest that genetic tests are critical technique for diagnosis of GADEVS, especially in patients with early-childhood, unexplained developmental or growth disorders, thus, the prevalence of GADEVS may be underestimated. The clinical features and identified YY1 mutation in our patient expand the spectra of phenotypes and genotypes of GADEVS, respectively.


Asunto(s)
Anomalías Craneofaciales/genética , Discapacidades del Desarrollo/genética , Insuficiencia de Crecimiento/genética , Factor de Transcripción YY1/genética , Anomalías Craneofaciales/patología , Discapacidades del Desarrollo/patología , Insuficiencia de Crecimiento/patología , Femenino , Mutación de Línea Germinal , Haploinsuficiencia , Humanos , Lactante , Síndrome
5.
Behav Brain Res ; 378: 112262, 2020 01 27.
Artículo en Inglés | MEDLINE | ID: mdl-31562903

RESUMEN

BACKGROUND: Regression is frequently described in Autism spectrum disorder (ASD). Limited comprehensive studies have been conducted in patients with ASD with regression. PURPOSE: To explore the network topological properties in ASD children with (ASD-R) and without (ASD-NR) regression. METHODS: In this study, 29 ASD-R, 68 ASD-NR, and 40 children with developmental delay (DD) were recruited. We utilized graph theory to characterize the white matter structure networks by using diffusion tensor imaging and T1-weighted imaging on a 3-T magnetic resonance system. Statistical analyses were performed using IBM SPSS (version 23). RESULTS: ANCOVA showed significant differences in global efficiency, characteristic path length and sigma among the ASD-R, ASD-NR and DD groups, but the difference was not significant between the ASD-R and ASD-NR groups. There were 10 common hubs based on regional degree and regional efficiency in all groups. The hubness of the left superior frontal gyrus-dorsolateral, left middle occipital gyrus and right precuneus were enhanced (by regional degree) and that of the right thalamus was reduced (by regional efficiency) in the ASD-R relative to the ASD-NR group. After controlling for the course of regression, the CARS scores were significantly correlated with the regional efficiency of the right precuneus in the ASD-R group. CONCLUSIONS: The ASD-R children were different from the ASD-NR children in the distribution of hub regions, although there were no global network property differences between them. In ASD-R children, the right precuneus (PCUN.R) might play an important role and relate to autism symptom severity.


Asunto(s)
Trastorno del Espectro Autista/patología , Trastorno del Espectro Autista/fisiopatología , Corteza Cerebral/patología , Discapacidades del Desarrollo/patología , Red Nerviosa/patología , Tálamo/patología , Sustancia Blanca/patología , Trastorno del Espectro Autista/diagnóstico por imagen , Corteza Cerebral/diagnóstico por imagen , Preescolar , Discapacidades del Desarrollo/diagnóstico por imagen , Femenino , Humanos , Masculino , Red Nerviosa/diagnóstico por imagen , Lóbulo Parietal/diagnóstico por imagen , Lóbulo Parietal/patología , Índice de Severidad de la Enfermedad , Tálamo/diagnóstico por imagen , Sustancia Blanca/diagnóstico por imagen
6.
Neurotoxicology ; 56: 64-75, 2016 09.
Artículo en Inglés | MEDLINE | ID: mdl-27395752

RESUMEN

Selective estrogen receptor modulators (SERMs) are a class of therapeutic chemicals which present tissue-specific estrogen receptor modulating activity. Neonatal exposure to SERMs has been reported to adversely affect central nervous system development, however, mechanism and involvement of hypothalamic kisspeptin neurone in this impairment remains undetermined. To clarify this uncertainty, neonates from female Donryu rats were subcutaneously injected with raloxifene (RLX) at 0.1, 1, and 10mg/kg or tamoxifen (TMX) at 10mg/kg on postnatal day 0, and then hypothalamic KiSS1 mRNA expression and gonadotropin levels were investigated during young adulthood and estrous cycling was monitored until middle age. Treatment with RLX or TMX at 10mg/kg significantly depressed luteinizing hormone surge levels and KiSS1 mRNA expression in the anteroventral periventricular nucleus (AVPV), the control center of estrous cyclicity. The 10mg/kg TMX group also showed decreased levels of follicle-stimulating hormone and KiSS1 mRNA expression in the arcuate nucleus (ARC). Early cessation of normal estrous cycling was observed in the 10mg/kg RLX group, while the estrous cycle in the 10mg/kg TMX group had ceased by the start of the analysis. The same dose of tamoxifen or raloxifene had either weak-estrogenic or anti-estrogenic activity on the uterus, respectively; however, treatment in adulthood with both SERMs did not affect KiSS1 mRNA expression in either the AVPV or ARC in the present study. These results indicate that neonatal exposure to SERMs could disrupt neuroendocrine development and postnatal reproductive function through the alteration of kisspeptin neurons.


Asunto(s)
Discapacidades del Desarrollo/inducido químicamente , Enfermedades del Sistema Endocrino/inducido químicamente , Hipotálamo/patología , Kisspeptinas/metabolismo , Neuronas/metabolismo , Moduladores Selectivos de los Receptores de Estrógeno/toxicidad , Factores de Edad , Animales , Animales Recién Nacidos , Peso Corporal/efectos de los fármacos , Discapacidades del Desarrollo/patología , Modelos Animales de Enfermedad , Enfermedades del Sistema Endocrino/patología , Estradiol/análogos & derivados , Estradiol/farmacología , Ciclo Estral/efectos de los fármacos , Femenino , Hormonas/metabolismo , Hipotálamo/efectos de los fármacos , Kisspeptinas/genética , Neuronas/efectos de los fármacos , Ovariectomía , Embarazo , Progesterona/farmacología , Clorhidrato de Raloxifeno/farmacología , Ratas , Tamoxifeno/farmacología
7.
Behav Brain Res ; 291: 289-298, 2015 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-26014855

RESUMEN

Chronic placental insufficiency and subsequent intrauterine growth restriction (IUGR) increase the risk of hypoxic-ischemic encephalopathy in the newborn by 40 fold. The latter, in turn, increases the risk of cerebral palsy and developmental disabilities. This study seeks to determine the effectiveness of broccoli sprouts (BrSp), a rich source of the isothiocyanate sulforaphane, as a neuroprotectant in a rat model of chronic placental insufficiency and IUGR. Placental insufficiency and IUGR was induced by bilateral uterine artery ligation (BUAL) on day E20 of gestation. Dams were fed standard chow or chow supplemented with 200mg of dried BrSp from E15 - postnatal day 14 (PD14). Controls received Sham surgery and the same dietary regime. Pups underwent neurologic reflex testing and open field testing, following which they were euthanized and their brains frozen for neuropathologic assessment. Compared to Sham, IUGR pups were delayed in attaining early reflexes and performed worse in the open field, both of which were significantly improved by maternal supplementation of BrSp (p<0.05). Neuropathology revealed diminished white matter, ventricular dilation, astrogliosis and reduction in hippocampal neurons in IUGR animals compared to Sham, whereas broccoli sprout supplementation improved outcome in all histological assessments (p<0.05). Maternal dietary supplementation with BrSp prevented the detrimental neurocognitive and neuropathologic effects of chronic intrauterine ischemia. These findings suggest a novel approach for prevention of cerebral palsy and/or developmental disabilities associated with placental insufficiency.


Asunto(s)
Encefalopatías/prevención & control , Encéfalo/patología , Brassica , Fenómenos Fisiologicos Nutricionales Maternos , Insuficiencia Placentaria/dietoterapia , Plantones , Animales , Animales Recién Nacidos , Encefalopatías/patología , Parálisis Cerebral/patología , Parálisis Cerebral/fisiopatología , Parálisis Cerebral/prevención & control , Discapacidades del Desarrollo/patología , Discapacidades del Desarrollo/fisiopatología , Discapacidades del Desarrollo/prevención & control , Suplementos Dietéticos , Modelos Animales de Enfermedad , Femenino , Masculino , Actividad Motora/fisiología , Insuficiencia Placentaria/mortalidad , Insuficiencia Placentaria/patología , Insuficiencia Placentaria/fisiopatología , Embarazo , Distribución Aleatoria , Ratas Long-Evans , Reflejo/fisiología
8.
Eur J Paediatr Neurol ; 19(1): 15-28, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25305700

RESUMEN

BACKGROUND: Damage to the developing brain may lead to lifelong motor impairments namely of the hand function. Playing an instrument combines the execution of gross and fine motor movements with direct auditory feedback of performance and with emotional value. This motor-associated sensory information may work as a self-control of motor performance in therapeutic settings. AIMS: The current study examined the occurrence of neuronal changes associated to piano training in youths with neurodevelopmental-associated hand motor deficits. METHODS: Functional magnetic resonance imaging responses evoked during a finger tapping task in a group of ten youths with neuromotor impairments that received individualized piano lessons for eighteen months were analyzed. Functional imaging data obtained before and after the piano training was compared to that obtained from a similar group of six youths who received no training during the same period of time. RESULTS: Dynamic causal modeling of functional data indicated an increase in positive connectivity from the left primary motor cortical area to the right cerebellum from before to after the piano training. CONCLUSIONS: A wide variability across patients was observed and further studies remain necessary to clarify the neurophysiological basis of the effects of piano training in hand motor function of patients with neurodevelopmental motor disorders.


Asunto(s)
Discapacidades del Desarrollo/patología , Discapacidades del Desarrollo/rehabilitación , Imagen por Resonancia Magnética/métodos , Trastornos del Movimiento/patología , Trastornos del Movimiento/rehabilitación , Musicoterapia/métodos , Plasticidad Neuronal , Estimulación Acústica , Adolescente , Niño , Discapacidades del Desarrollo/fisiopatología , Emociones , Retroalimentación Psicológica , Femenino , Lateralidad Funcional/fisiología , Mano/fisiopatología , Humanos , Procesamiento de Imagen Asistido por Computador , Inteligencia , Masculino , Modelos Neurológicos , Corteza Motora/fisiopatología , Trastornos del Movimiento/fisiopatología , Pruebas Neuropsicológicas , Desempeño Psicomotor/fisiología , Resultado del Tratamiento
9.
Brain Struct Funct ; 220(1): 307-18, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24146132

RESUMEN

Preservation of thalamocortical projections to the sensorimotor cortex is related to improved hand function in children with cerebral palsy (CP). Whether CP is associated with altered microstructure of these sensorimotor projections or other thalamocortical pathways remains unclear. Forty-two children with congenital hemiplegia and fifteen typically developing children (TDC) underwent structural and diffusion-weighted imaging (high-angular-resolution diffusion imaging) using a 3T MRI. Structural T1-images were parcellated into 34 cortical regions and the thalamus per hemisphere. Thalamocortical projections were extracted using probabilistic tractography and the top tan cortical regions with the greatest number of thalamocortical streamlines for the TDC group were selected for further analysis. The thalamus was parcellated based on its cortical connections. Differences between hemispheres for thalamocortical streamline numbers to each cortical region [asymmetry index (AI)], tract volume and tract microstructure [weighted mean fractional anisotropy (FA) and mean diffusivity (MD)] were calculated. Correlations between these measures (AI, FA and MD) and sensorimotor function were performed. Thalamocortical projections showed topographical organisation based on cortical connectivity. Projections to paracentral lobule, pre-central and post-central gyri showed greater AI in CP group, which indicates reduced streamlines on the ipsilesioned hemisphere. Reduced FA, reduced tract volume and increased MD were also found for these thalamocortical projections on the ipsilesioned hemisphere in children with CP. Changes in AI and tract microstructure of these projections were associated with poorer sensorimotor function. The findings suggest CP is associated with reorganisation of thalamocortical projections to the sensorimotor cortex. Integrity in these projections may underpin deficits in sensorimotor function.


Asunto(s)
Parálisis Cerebral/patología , Discapacidades del Desarrollo/patología , Vías Nerviosas/patología , Corteza Sensoriomotora/patología , Tálamo/patología , Adolescente , Mapeo Encefálico , Parálisis Cerebral/complicaciones , Niño , Preescolar , Discapacidades del Desarrollo/etiología , Imagen de Difusión por Resonancia Magnética , Femenino , Humanos , Procesamiento de Imagen Asistido por Computador , Imagen por Resonancia Magnética , Masculino , Vías Nerviosas/crecimiento & desarrollo , Índice de Severidad de la Enfermedad , Tálamo/crecimiento & desarrollo
10.
Pediatr Neurol ; 50(5): 447-51, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24656462

RESUMEN

BACKGROUND: Magnetic resonance imaging is a surrogate biomarker for major neurodevelopmental disabilities in survivors of perinatal hypoxic-ischemic encephalopathy because injury to the basal ganglia/thalami is highly predictive of major neuromotor and cognitive problems. Major disabilities and the appearance of neonatal magnetic resonance imaging are improved with therapeutic hypothermia. We evaluated neurodevelopmental outcomes when conventional magnetic resonance imaging showed minimal or no brain injury. METHODS: Institutional review board-approved series of 62 infants (≥36 weeks; ≥1800 g; 34 boys/28 girls) cooled for hypoxic-ischemic encephalopathy between 2005 and 2011 who underwent neonatal magnetic resonance imaging and Bayley Scales of Infant and Toddler Development-III at 22 ± 7 months of age. Magnetic resonance imaging at 5-14 (mean 8) days was scored as normal (score = 0), showing focal gray or white matter injury only (score = 1), or basal ganglia/thalamic and/or watershed lesions with or without more extensive hemispheric injury (score = 2). Sensitivity, specificity, and positive and negative predictive values for magnetic resonance scores 0 and 1 and statistical interaction between magnetic resonance imaging score and age at magnetic resonance imaging were determined. RESULTS: Magnetic resonance score = 0 was seen in 35/62 patients; 26/35 (74%) were typically developing, seven (20%) had moderate and two (6%) had severe delay. Magnetic resonance score = 1 was seen in 17/62 (27%) patients; 5/17 (29%) were normal, 11/17 (65%) had moderate delay, and 1/17 (6%) had severe neurodevelopmental delay. Of the 52 patients with magnetic resonance scores of 0 and 1, 40% were abnormal. The negative predictive value of a normal magnetic resonance imaging was 74%. For score 1, sensitivity was 95% (confidence interval 63%-83%), specificity 84% (confidence interval 70%-90%), positive predictive value 84% (confidence interval 71%-93%), and negative predictive value 74% (confidence interval 62%-82%). CONCLUSIONS: Caution is warranted when prognosticating about neurodevelopmental status in early childhood after hypoxic ischemic encephalopathy with cooling, and longer follow-up studies are needed to determine the prognostic significance of a neonatal magnetic resonance imaging showing no or minor degrees of brain injury.


Asunto(s)
Encéfalo/patología , Hipoxia-Isquemia Encefálica/diagnóstico , Hipoxia-Isquemia Encefálica/patología , Imagen por Resonancia Magnética , Ganglios Basales/patología , Encéfalo/crecimiento & desarrollo , Desarrollo Infantil , Discapacidades del Desarrollo/diagnóstico , Discapacidades del Desarrollo/etiología , Discapacidades del Desarrollo/patología , Femenino , Estudios de Seguimiento , Humanos , Hipoxia-Isquemia Encefálica/complicaciones , Hipoxia-Isquemia Encefálica/terapia , Lactante , Recién Nacido , Masculino , Fibras Nerviosas Mielínicas/patología , Fibras Nerviosas Amielínicas/patología , Pruebas Neuropsicológicas , Pronóstico , Sensibilidad y Especificidad , Índice de Severidad de la Enfermedad , Tálamo/patología
12.
Magn Reson Med ; 70(6): 1707-17, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23400959

RESUMEN

PURPOSE: Our aim in this study was to apply three-dimensional MRI methods to analyze early postnatal morphological phenotypes in a Gbx2 conditional knockout (Gbx2-CKO) mouse that has variable midline deletions in the central cerebellum, reminiscent of many human cerebellar hypoplasia syndromes. METHODS: In vivo three-dimensional manganese-enhanced MRI at 100-µm isotropic resolution was used to visualize mouse brains between postnatal days 3 and 11, when cerebellum morphology undergoes dramatic changes. Deformation-based morphometry and volumetric analysis of manganese-enhanced MRI images were used to, respectively, detect and quantify morphological phenotypes in Gbx2-CKO mice. Ex vivo micro-MRI was performed after perfusion-fixation with supplemented gadolinium for higher resolution (50-µm) analysis. RESULTS: In vivo manganese-enhanced MRI and deformation-based morphometry correctly identified known cerebellar defects in Gbx2-CKO mice, and novel phenotypes were discovered in the deep cerebellar nuclei and the vestibulo-cerebellum, both validated using histology. Ex vivo micro-MRI revealed subtle phenotypes in both the vestibulo-cerebellum and the vestibulo-cochlear organ, providing an interesting example of complementary phenotypes in a sensory organ and its associated brain region. CONCLUSION: These results show the potential of three-dimensional MRI for detecting and analyzing developmental defects in mouse models of neurodevelopmental diseases.


Asunto(s)
Cerebelo/anomalías , Cerebelo/patología , Proteínas de Homeodominio/genética , Imagen por Resonancia Magnética/métodos , Malformaciones del Sistema Nervioso/patología , Vestíbulo del Laberinto/anomalías , Vestíbulo del Laberinto/patología , Animales , Animales Recién Nacidos , Cerebelo/crecimiento & desarrollo , Cerebelo/fisiopatología , Discapacidades del Desarrollo/genética , Discapacidades del Desarrollo/patología , Discapacidades del Desarrollo/fisiopatología , Ratones , Ratones Noqueados , Malformaciones del Sistema Nervioso/genética , Malformaciones del Sistema Nervioso/fisiopatología , Fenotipo , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Vestíbulo del Laberinto/crecimiento & desarrollo
13.
Neuropediatrics ; 44(4): 208-12, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23341096

RESUMEN

Maple syrup urine disease (MSUD) is a rare inherited metabolic disorder resulting from the defective activity of branched-chain 2-ketoacid dehydrogenase complex. Routine screening of newborn with tandem mass spectroscopy on the third day of life may detect elevated branched-chain amino acids in blood before the appearance of encephalopathic symptoms in MSUD cases. If undiagnosed by such a routine screening test, patients often present with encephalopathy and seizures. Clinical neurologic examination is supplemented by electroencephalography and imaging. Here, we report abnormal amplitude-integrated electroencephalography, electroencephalography, magnetic resonance imaging, and magnetic resonance imaging spectroscopy findings in a neurologically asymptomatic male newborn who was diagnosed with MSUD at the third week of life. These neurologic disturbances disappeared at the fourth month of life with appropriate special diet. Therefore, even in already asymptomatic cases, early neurologic deterioration of brain metabolism and structure can be detected with these early laboratory findings, indicating the importance of early diagnosis and management. Patients may also benefit from these investigations during the follow-up period.


Asunto(s)
Encefalopatías/etiología , Discapacidades del Desarrollo/etiología , Enfermedad de la Orina de Jarabe de Arce/complicaciones , Enfermedad de la Orina de Jarabe de Arce/diagnóstico , Ácido Aspártico/análogos & derivados , Ácido Aspártico/metabolismo , Encefalopatías/dietoterapia , Ondas Encefálicas/fisiología , Consanguinidad , Discapacidades del Desarrollo/patología , Dieta , Dieta Baja en Carbohidratos/métodos , Electroencefalografía , Humanos , Recién Nacido , Inositol/metabolismo , Ácido Láctico/metabolismo , Imagen por Resonancia Magnética , Espectroscopía de Resonancia Magnética , Masculino , Enfermedad de la Orina de Jarabe de Arce/dietoterapia
14.
J Neurosci ; 32(43): 15106-11, 2012 Oct 24.
Artículo en Inglés | MEDLINE | ID: mdl-23100431

RESUMEN

Accumulative evidence indicates that microglial cells influence the normal development of brain synapses. Yet, the mechanisms by which these immune cells target maturating synapses and influence their functional development at early postnatal stages remain poorly understood. Here, we analyzed the role of CX3CR1, a microglial receptor activated by the neuronal chemokine CX3CL1 (or fractalkine) which controls key functions of microglial cells. In the whisker-related barrel field of the mouse somatosensory cortex, we show that the recruitment of microglia to the sites where developing thalamocortical synapses are concentrated (i.e., the barrel centers) occurs only after postnatal day 5 and is controlled by the fractalkine/CX3CR1 signaling pathway. Indeed, at this developmental stage fractalkine is overexpressed within the barrels and CX3CR1 deficiency delays microglial cell recruitment into the barrel centers. Functional analysis of thalamocortical synapses shows that CX3CR1 deficiency also delays the functional maturation of postsynaptic glutamate receptors which normally occurs at these synapses between the first and second postnatal week. These results show that reciprocal interactions between neurons and microglial cells control the functional maturation of cortical synapses.


Asunto(s)
Discapacidades del Desarrollo/patología , Receptores de Quimiocina/deficiencia , Corteza Somatosensorial/patología , Sinapsis/patología , Tálamo/patología , Factores de Edad , Animales , Animales Recién Nacidos , Receptor 1 de Quimiocinas CX3C , Quimiocina CX3CL1/metabolismo , Discapacidades del Desarrollo/genética , Estimulación Eléctrica , Antagonistas de Aminoácidos Excitadores/farmacología , Potenciales Postsinápticos Excitadores/genética , Potenciales Postsinápticos Excitadores/fisiología , Femenino , Antagonistas del GABA/farmacología , Regulación del Desarrollo de la Expresión Génica/genética , Proteínas Fluorescentes Verdes/genética , Técnicas In Vitro , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Microglía/metabolismo , Receptores de Quimiocina/genética , Proteínas de Transporte de Serotonina en la Membrana Plasmática/metabolismo , Estadísticas no Paramétricas
15.
Behav Brain Res ; 235(2): 166-75, 2012 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-22867871

RESUMEN

While variations in neonatal distress vocalizations have long been shown to reflect the integrity of nervous system development following a wide range of prenatal and perinatal insults, a paucity of research has explored the neurobiological basis of these variations. To address this, virgin Sprague-Dawley rats were bred and divided into three groups: [1] untreated, [2] chronic-cocaine treated (30 mg/kg/day, gestation days (GDs) 1-20); or [3] chronic saline treated (2 mg/kg/day, GDs 1-20). Pregnant dams were injected with Bromodeoxyuridine (10 mg/kg) on GDs 13-15 to label proliferating cells in limbic regions of interest. Ultrasonic vocalizations (USVs) were recorded on postnatal days (PNDs) 1, 14, and 21, from one male and female pup per litter. Variations in acoustic properties of USVs following cocaine-exposure were age and sex-dependent including measures of total number, total duration and amplitude of USVs, and percent of USVs with at least one harmonic. Following USV testing brains were stained with standard fluorescent immunohistochemistry protocols and examined for variations in neuronal development and if variations were associated with acoustic characteristics. Limbic region developmental differences following cocaine-exposure were sex- and age-dependent with variations in the ventral medial hypothalamus and central amygdala correlating with variations in vocalizations on PND 14 and 21. Results suggest maturation of the ventral medial hypothalamus and central amygdala may provide the basis for variations in the sound and production of USVs. As vocalizations may serve as a neurobehavioral marker for nervous system integrity, understanding the neurobiological basis of neonatal vocalizations may provide the basis for early intervention strategies in high-risk infant populations.


Asunto(s)
Amígdala del Cerebelo/fisiopatología , Cocaína/efectos adversos , Discapacidades del Desarrollo/patología , Inhibidores de Captación de Dopamina/efectos adversos , Hipotálamo Medio/fisiopatología , Efectos Tardíos de la Exposición Prenatal/fisiopatología , Vocalización Animal/fisiología , Estimulación Acústica , Factores de Edad , Amígdala del Cerebelo/crecimiento & desarrollo , Análisis de Varianza , Animales , Animales Recién Nacidos , Bromodesoxiuridina/metabolismo , Recuento de Células , Proliferación Celular , Discapacidades del Desarrollo/etiología , Modelos Animales de Enfermedad , Femenino , Análisis de Fourier , Edad Gestacional , Hipotálamo Medio/crecimiento & desarrollo , Masculino , Fosfopiruvato Hidratasa/metabolismo , Embarazo , Ratas , Ratas Sprague-Dawley , Factores Sexuales , Factores de Tiempo
16.
Cereb Cortex ; 22(4): 754-64, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21693783

RESUMEN

Phonological awareness, knowledge that speech is composed of syllables and phonemes, is critical for learning to read. Phonological awareness precedes and predicts successful transition from language to literacy, and weakness in phonological awareness is a leading cause of dyslexia, but the brain basis of phonological awareness for spoken language in children is unknown. We used functional magnetic resonance imaging to identify the neural correlates of phonological awareness using an auditory word-rhyming task in children who were typical readers or who had dyslexia (ages 7-13) and a younger group of kindergarteners (ages 5-6). Typically developing children, but not children with dyslexia, recruited left dorsolateral prefrontal cortex (DLPFC) when making explicit phonological judgments. Kindergarteners, who were matched to the older children with dyslexia on standardized tests of phonological awareness, also recruited left DLPFC. Left DLPFC may play a critical role in the development of phonological awareness for spoken language critical for reading and in the etiology of dyslexia.


Asunto(s)
Trastornos de la Articulación/etiología , Concienciación/fisiología , Mapeo Encefálico , Encéfalo/patología , Discapacidades del Desarrollo , Dislexia , Fonética , Estimulación Acústica , Adolescente , Análisis de Varianza , Trastornos de la Articulación/patología , Encéfalo/irrigación sanguínea , Estudios de Casos y Controles , Niño , Preescolar , Discapacidades del Desarrollo/patología , Discapacidades del Desarrollo/fisiopatología , Dislexia/complicaciones , Dislexia/patología , Dislexia/psicología , Femenino , Humanos , Procesamiento de Imagen Asistido por Computador , Imagen por Resonancia Magnética/métodos , Masculino , Oxígeno/sangre , Psicoacústica , Tiempo de Reacción , Lectura , Vocabulario
17.
Neurology ; 76(24): 2055-61, 2011 Jun 14.
Artículo en Inglés | MEDLINE | ID: mdl-21670434

RESUMEN

OBJECTIVES: Central gray matter damage, the hallmark of term acute perinatal hypoxia-ischemia, frequently leads to severe cerebral palsy and sometimes death. The precision with which these outcomes can be determined from neonatal imaging has not been fully explored. We evaluated the accuracy of early brain MRI for predicting death, the presence and severity of motor impairment, and ability to walk at 2 years in term infants with hypoxic-ischemic encephalopathy (HIE) and basal ganglia-thalamic (BGT) lesions. METHODS: From 1993 to 2007, 175 term infants with evidence of perinatal asphyxia, HIE, and BGT injury seen on early MRI scans were studied. BGT, white matter, posterior limb of the internal capsule (PLIC), and cortex and brainstem abnormality were classified by severity. Motor impairment was staged using the Gross Motor Function Classification System. RESULTS: The severity of BGT lesions was strongly associated with the severity of motor impairment (Spearman rank correlation 0.77; p < 0.001). The association between white matter, cortical, and brainstem injury and motor impairment was less strong and only BGT injury correlated significantly in a logistic regression model. The predictive accuracy of severe BGT lesions for severe motor impairment was 0.89 (95% confidence interval 0.83-0.96). Abnormal PLIC signal intensity predicted the inability to walk independently by 2 years (sensitivity 0.92, specificity 0.77, positive predictive value 0.88, negative predictive value 0.85). Brainstem injury was the only factor with an independent association with death. CONCLUSION: We have shown that in term newborns with HIE and BGT injury, early MRI can be used to predict death and specific motor outcomes.


Asunto(s)
Hipoxia-Isquemia Encefálica/complicaciones , Hipoxia-Isquemia Encefálica/mortalidad , Hipoxia-Isquemia Encefálica/patología , Trastornos del Movimiento/etiología , Trastornos del Movimiento/patología , Trastornos del Movimiento/fisiopatología , Caminata , Ganglios Basales/patología , Discapacidades del Desarrollo/etiología , Discapacidades del Desarrollo/patología , Discapacidades del Desarrollo/fisiopatología , Humanos , Hipoxia-Isquemia Encefálica/fisiopatología , Lactante , Recién Nacido , Cápsula Interna/patología , Imagen por Resonancia Magnética/métodos , Valor Predictivo de las Pruebas , Estudios Retrospectivos , Tálamo/patología
18.
Int J Dev Neurosci ; 26(2): 225-31, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18207350

RESUMEN

Barrel formation is delayed in nutritionally restricted rats. The underlying cause of such delay is yet unclear. Because barrels appear upon the arrival of somatosensory thalamo-cortical afferents and the reorientation of the dendritic arborizations of cortical spiny stellate neurons, it is likely that at least one of these processes is altered by nutritional restriction. Also, the serotoninergic afferent system has been implicated in regulating barrel segregation and growth during early postnatal life. We then evaluated the pattern of immunostaining of the serotonin transporter (SERT) and of the serotonin receptor 1B (5-HT(1B)), as well as the growth and arrival time of somatosensory thalamo-cortical afferents, to infer the contribution of these elements in the delayed formation of barrels observed in nutritionally restricted rats. It was found that the rates of development and the segregation of thalamo-cortical fibers were normal in nutritionally restricted rats. SERT, but not 5-HT(1B) immunoreactivity, was decreased in the primary somatosensory cortex during barrel specification. The availability of both proteins in nutritionally restricted rats was lower than that observed in their well fed counterparts at later developmental times. It is concluded that the delayed formation of barrels observed in nutritionally restricted rats is due to a retarded reorientation of dendritic arbors of cortical neurons. This might happen as a secondary effect of decreasing the availability of SERT and/or increasing the availability of 5-HT(1B) receptor early in postnatal life.


Asunto(s)
Desnutrición/complicaciones , Receptor de Serotonina 5-HT1B/metabolismo , Proteínas de Transporte de Serotonina en la Membrana Plasmática/metabolismo , Serotonina/metabolismo , Corteza Somatosensorial/crecimiento & desarrollo , Tálamo/crecimiento & desarrollo , Envejecimiento/fisiología , Animales , Animales Recién Nacidos , Restricción Calórica , Comunicación Celular/fisiología , Diferenciación Celular/fisiología , Trastornos de la Nutrición del Niño/complicaciones , Preescolar , Señales (Psicología) , Discapacidades del Desarrollo/metabolismo , Discapacidades del Desarrollo/patología , Discapacidades del Desarrollo/fisiopatología , Privación de Alimentos/fisiología , Conos de Crecimiento/metabolismo , Conos de Crecimiento/patología , Humanos , Inmunohistoquímica , Lactante , Desnutrición/fisiopatología , Vías Nerviosas/crecimiento & desarrollo , Vías Nerviosas/metabolismo , Vías Nerviosas/fisiopatología , Ratas , Ratas Wistar , Corteza Somatosensorial/metabolismo , Corteza Somatosensorial/fisiopatología , Tálamo/metabolismo , Tálamo/fisiopatología
19.
Ann Neurol ; 52(4): 458-64, 2002 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12325075

RESUMEN

Cerebral 18F-fluorodeoxyglucose positron emission tomography in 14 patients with microcephaly, developmental delay, seizures, and mutations of the glucose transporter Glut1 (Glut1 deficiency syndrome) showed distinct abnormalities. Within a global context of diminished cortical uptake, more severe hypometabolism was found in the mesial temporal regions and thalami, accentuating a relative signal increase in the basal ganglia. In contrast, the structure of the brain appeared preserved in patients additionally investigated by magnetic resonance imaging. This metabolic footprint was relatively constant in all patients regardless of age, seizure history, or therapies and therefore constitutes a radiological signature of the disease. The full expression of the signature in the youngest patient (aged 19 months) indicates that the state of haploinsufficiency caused by Glut1 mutation leaves a permanent footprint on the nervous system from its earlier postnatal stages of development. The potential benefit of prompt diagnosis, aided by 18F-fluorodeoxyglucose positron emission tomography, and early initiation of available therapies is underscored by our results.


Asunto(s)
Encefalopatías/diagnóstico por imagen , Encefalopatías/metabolismo , Proteínas de Transporte de Monosacáridos/deficiencia , Adolescente , Adulto , Factores de Edad , Encefalopatías/patología , Corteza Cerebral/metabolismo , Niño , Discapacidades del Desarrollo/diagnóstico por imagen , Discapacidades del Desarrollo/metabolismo , Discapacidades del Desarrollo/patología , Epilepsia/diagnóstico por imagen , Epilepsia/metabolismo , Epilepsia/patología , Femenino , Fluorodesoxiglucosa F18 , Glucosa/farmacocinética , Transportador de Glucosa de Tipo 1 , Humanos , Lactante , Masculino , Microcefalia/diagnóstico por imagen , Microcefalia/metabolismo , Microcefalia/patología , Radiofármacos , Tálamo/metabolismo , Tomografía Computarizada de Emisión
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA